ProActive Capital Group Announces Sponsorship at 2012 Aegis Healthcare Conference
ProActive's Life Science Practice Continues to Show Solid Growth
NEW YORK, Sept. 27, 2012 /PRNewswire/ -- ProActive Capital Group, a leading life science capital markets advisory and strategic communications firm, announced its sponsorship at the 2012 Aegis Healthcare Conference at The Wynn in Las Vegas, Nevada September 27th and 28th.
A leader in capital markets advisory and strategic communications specifically for the life sciences sector, ProActive Capital Group is pioneering new ways in which companies strategically and proactively communicate with all of their stakeholders and potential investors.
"As we continue to rapidly grow and further build out our presence in the life sciences sector it is an opportune time to be a sponsor at the Aegis Healthcare Conference," stated Jeff Ramson, Founder and CEO of ProActive Capital Group. "Establishing credibility and building awareness are of the utmost importance for emerging life sciences companies and conferences such as this are an ideal environment to gain exposure within the investment community."
Aegis' Healthcare Conference is a senior level, interactive conference designed to educate both the retail and institutional investor. This two-day event will feature more than 20 companies within the life science space. Presenting companies will be showcased through a combination of company presentations, Q&A sessions, and one-on-one meetings. Companies currently planned to present include:
Advence Technology Inc. (ACTC) Ampio Pharmaceuticals Inc. (AMPE) AspenBio Pharma (APPY) AtheroNova Inc. (AHRO) Bio specifics (BSTC) Biomerix Celsion Corp (CLSN) Chromadex (CDXC) CytRx Corporation (CYTR) FlouroPharma Medical (FPMI) Galectin Therapeutics (GALT) Galena Biopharma (GALE) IntelGenx Corporation (IGXT) Invivo Therapeutics (NVIV) Lpath Inc. (LPTN) Neuralstem (CUR) NovaBay Pharmaceuticals (NBY) PURE Biosciences (PURE) Rosetta Genomics (ROSG) SciClone Pharmaceuticals Inc. (SCLN) Spectrum Pharmaceuticals, Inc. (SPPI) Synergy Pharmaceuticals, Inc (SGYP) Tonix Pharmaceuticals Holding Corp (TNXP) Trovagene Inc. (TROV) VentriPoint Diagnostics Ltd. (VPTDF) |
About ProActive Capital Group, LLC
ProActive Capital Group, LLC ("PCG") is dedicated to the discovery and creation of value specifically for the life sciences, micro-small cap marketplace. PCG provides unique solutions that combine capital market advisory and strategic communications. Our overarching goal is to develop and leverage stakeholder awareness from all key constituents in order to maximize shareholder value. PCG's capital market advisory services include overall investor strategy development to increase and leverage investor awareness, visibility & credibility. PCG's strategic communications services leverage digital media channels to further increase awareness to all key constituents. Communicating the client's story accurately and effectively is tantamount to maximizing exposure to its current and potential stakeholders.
Contact:
Jeff Ramson
Proactive Capital Group, LLC.
212-863-6341
[email protected]
SOURCE ProActive Capital Group
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article